BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34177909)

  • 1. Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms.
    Ru Y; Ding X; Luo Y; Li H; Sun X; Zhou M; Zhou Y; Kuai L; Xing M; Liu L; Luo Y; Song J; Chen J; Li B; Li X
    Front Immunol; 2021; 12():670398. PubMed ID: 34177909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review.
    Wang J; Wang C; Liu L; Hong S; Ru Y; Sun X; Chen J; Zhang M; Lin N; Li B; Li X
    Front Immunol; 2023; 14():993057. PubMed ID: 36817423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
    Ryan C; Leonardi CL; Krueger JG; Kimball AB; Strober BE; Gordon KB; Langley RG; de Lemos JA; Daoud Y; Blankenship D; Kazi S; Kaplan DH; Friedewald VE; Menter A
    JAMA; 2011 Aug; 306(8):864-71. PubMed ID: 21862748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha inhibitors for ankylosing spondylitis.
    Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for pityriasis rosea.
    Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis.
    Schneider-Thoma J; Efthimiou O; Bighelli I; Dörries C; Huhn M; Krause M; Reichelt L; Röder H; Furukawa TA; Davis JM; Leucht S
    Lancet Psychiatry; 2019 Sep; 6(9):753-765. PubMed ID: 31320283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
    Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Johnston BC; Goldenberg JZ; Vandvik PO; Sun X; Guyatt GH
    Cochrane Database Syst Rev; 2011 Nov; (11):CD004827. PubMed ID: 22071814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
    Hayes SR; Vargas AJ
    Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
    Tzellos T; Kyrgidis A; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):622-7. PubMed ID: 22404103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
    Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
    Singh S; Stroud AM; Holubar SD; Sandborn WJ; Pardi DS
    Cochrane Database Syst Rev; 2015 Nov; (11):CD001176. PubMed ID: 26593456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.